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Available online 18 August 2015AbstractPurpose: The aim of this study is to evaluate clinical characteristics of osteoporosis management in patients with Parkinson's disease.
Materials and methods: Data on patients with Parkinson's disease was collected from March, 2000 to March, 2013 at single institution. We
investigated portion of BMD test, portion of diagnosed osteoporosis, portion of pharmacological treatment, prevalence and location of primary
fractures and presence of second-fractures after primary fracture on in patients with idiopathic Parkinson's disease.
Results: Total of 865 patients were included. Among the 865 subjects, the number of patients who underwent diagnostic studies was 189 (21.8%)
and the number of patients who was diagnosed with osteoporosis with BMD test was 72 (38.1%), which was 8.3% of the whole patients. Among
the patients diagnosed with osteoporosis, the number of patients who were administered with osteoporosis medication for more than 1 year was
49 (68.0%), which was 5.6% of the whole patients.
One hundred thirty (15.0%) patients suffered from low energy fractures. Of the 130 fracture sites, 57(43.3%) occurred in proximal femur, 47
(36.1%) of in vertebra, 8 (6.1%) in wrist, 4 (3.0%) in proximal humerus and 14 (10.7%) elsewhere. Twenty two (16.9%) patients suffered from
second fracture after the primary fracture.
Conclusion: In Parkinson's disease patients, the diagnosis and pharmacologic treatment of osteoporosis were not done adequately, and thus both
medical staffs and patients should take this matter into consideration.
Copyright © 2015 The Korean Society of Osteoporosis. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Parkinson's disease is the second most prevalent neuro-
pathic disorder after Alzheimer's disease in the world [1].
Common symptoms of Parkinson's disease include tremor,
rigidity, disturbance of postural reflexes, and the most com-
mon injury caused by posture instability and difficulty walking
is fall and related damage [2].* Corresponding author. Department of Orthopaedic Surgery, Konyang
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ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Forty six% of Parkinson's disease patients experienced
falling once every 3 months and a fracture occurred in about 1
out of every 4 [3e6]. The reasons why fracture in Parkinson's
disease occur frequently after falling are related to the increase
of the prevalence of osteoporosis due to decrease in exercise,
and vitamin D deficiency because of limitation in outdoor
activities and secondary hypoparathyroidism [7e9].
Parkinson's disease patients show higher rates of compli-
cations and deaths after surgery compared to people without
the disease [2].
However, there was no domestic research about prevalence
and treatment for osteoporosis in patients with Parkinson's
disease. Therefore, this study evaluated clinical characteristics
of osteoporosis management and fracture in Parkinson's dis-
ease patients.hosting by Elsevier B.V. This is an open access article under the CC BY-NC-
Table 2
Number of BMD test prescribed according to department.
Department Number of prescribed
BMD test (n ¼ 189)
Neurology 40 (21.1%)
Orthopedics 20 (10.5%)
Rehabilitation 23 (12.1%)
Endocrinology 21 (11.1%)
Family Medicine 20 (10.5%)
Other 65 (34.4%)
BMD: bone mineral density.
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This study was conducted in a single institution where they
receive 617,731 outpatients and 32,296 inpatients per year.
Data on patients with Parkinson's disease was collected from
March, 2000 to March, 2013 at a single institution. All pro-
cedures were approved by the internal review board of our
institution (KYUH 2015-05-009).
The data used KCD-6(Korean Standard Classification of
Diseases) for its diagnostic code and it was obtained using
G20-21 for Parkinson's disease and S32, 42, 52, 62, 72, 82,2,
T2, 10, 12 for fracture (primary diagnosis codes). Based on
this data, medical records and radiologic images, portion of
bone mineral density (BMD) test, portion of diagnosed oste-
oporosis, portion of pharmacological treatment, prevalence
and location of fractures and presence of second-fractures after
primary fracture on in patients with idiopathic Parkinson's
disease.
BMD was measured using dual energy X-ray absorptiom-
etry (DEXA) (lunar PPX-L, Medison, Wisconsin, USA). Ac-
cording to the WHO criteria, osteoporosis is defined as a BMD
that lies 2.5 standard deviations or more below the average
value (a T-score of <2.5 SD). In the BMD test was carried
out, the testing departments were investigated.
Patients whose fractures were confirmed by medical im-
aging and patients with fractures that resulted from low en-
ergy injury or without history of trauma were included. We
defined osteoporotic fracture sites as proximal femur, spine,
wrist, proximal humerus, and others (ankle, foot, distal hu-
merus, distal femur, proximal tibia), and second fracture was
defined as fracture developed sequentially after primary
fracture [10].
3. Results
Total of 865 patients were enrolled in the study. The
average age of patients was 64.8 ± 11 years. The male to
female ratio was 1:1.4 (Table 1). The number of patients that
underwent BMD test was 189 (21.8%) (Table 1). BMD test
was done 40 (21.1%) times at the neurology department, 23
(12.1%) times at the rehabilitation department, 21 (11.1%)
times at the endocrinology department, 20 (10.5%) times at
the orthopedics department, and 20 (10.5%) times at the
family medicine department (Table 2).
The number of patients diagnosed with osteoporosis after
the BMD test was 72 (38.1%) which was 8.3% of the wholeTable 1
Patient's demographic data.
Parkinson's disease patients (number) 865
Average age (y) 66.8
Gender ratio (male:female) 1:1.4
BMD test (number) 189
Diagnosed osteoporosis (number) 72
Pharmacologic treatment 49
Osteoporosis related fracture (number) 130
Secondary fracture (number) 22 (2.57%)
BMD: bone mineral density.865 patients. The mean BMD of 72 patients was 3.65 and
standard deviation was 0.7641 (95% confidence interval:
3.6313 to 3.6873). Among the patients diagnosed with
osteoporosis, the number of patients that underwent pharma-
cologic treatment for more than a year was 49 (68.0%).
One hundred thirty (15.0%) patients suffered from low
energy fractures. Of the 130 fracture sites, 57 (43.3%)
occurred in proximal femur, 47 (36.1%) in vertebra, 8 (6.1%)
in wrist, 4 (3.0%) in proximal humerus and 14 (10.7%) else-
where (Fig. 1A).
There were 67 (51.53%) patients who underwent BMD test
after fracture. The number of patients underwent BMD test
according to fracture type are 36 (46.6%) of spine, 20 (35.0%)
in proximal femur, 11 (14.1%) in wrist, 4 (3.0%) in proximal
humerus and 1 (7.1%) elsewhere (Fig. 1B).
Twenty-two (16.9%) patients suffered from second fracture
after the primary fracture. Second fractures occurred on the
same site as primary fracture in 6 (27.0%) patients (3 cases in
femur, 3 cases in spine).
4. Discussion
We enrolled Parkinson's disease patients by KCD-6 (Korean
Standard Classification of Diseases) diagnostic code. The
Parkinson's Disease Society criteria requires slowness of
movement plus either rigidity, resting tremor, or postural
instability. Other possible causes for these symptoms need to
be ruled out. Finally, three or more of the following features
are required during onset or evolution: unilateral onset, tremor
at rest, progression in time, asymmetry of motor symptoms,
response to levodopa for at least five years, clinical course of
at least ten years, and appearance of dyskinesia induced by the
intake of excessive levodopa [11].
In a study on the prevalence of osteoporosis in Parkinson's
disease patients Torsney [9] and Zaho [12] report that patients
with Parkinson's disease are at higher risk for osteoporosis and
have lower BMD levels than healthy controls.
In 2007, among those enlisted in the national health in-
surance claims database of Korea, 66.7% had underwent a
BMD test for osteoporosis. However, this data does not
include those who had the BMD test done as uninsured,
therefore the actual figure must be well above 66.7%. In this
study the rate of BMD test was 21.8%, but this is significantly
lower than the rate shown in the data based on the national
health insurance claims (66.7%) [13]. Authors thought that
Fig. 1. Percent of patients by fracture sites (A) and BMD test according
fracture sites (B). BMD: bone mineral density.
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disease, affected to resulting in low rate of BMD test because
this study conducted on Parkinson's disease patients.
Osteoporosis treatment in patients with Parkinson's disease
is the same as treatment for other patients [14,15]. 31.9% of
patients diagnosed with osteoporosis did not take medication
in this study and among them, 80.0% did not take medication
even with osteoporotic fractures. This result was different
from the reports those with fracture showed higher rate of
BMD test [16,17].
The majority of osteoporotic fractures usually involve the
proximal femur and the wrist, but spine fracture ratio is not
that high [18,19]. On the other hand, in our patients with
Parkinson's disease, the wrist showed lower incidence than hip
or spine. This result is clinically and economically very
important because hip fracture is more fatal than wrist.
Authors thought that this different rate resulted from
different gait posture and fall mechanism. Body center of
gravity in patients with Parkinson disease is more posteriorthan the normal axis and pelvis is inclined more anteriorly.
Some authors explained that the bradykinesia bothers fast and
exact correction of movement, loss of ocular vestibular reflex,
loss spinal reflex can be another reason [19e21].
As mentioned above, this study has a few limitations. First,
because this study was a conducted in a single institution,
preliminarily before a nationwide research, differences in the
factors such as patients' numbers, age range, characteristics,
and accessibility of the hospital may have caused differences.
In some investigation topics, there was limitation to give a
significant conclusion because of limited number of cases.
Second, we enrolled Parkinson's disease patients as defined by
KCD-6 diagnostic code, but there was no consideration of the
severity and stages of patients with Parkinson's disease [22].
Next study would need to make up for these weak points.
5. Conclusion
In Parkinson's disease patients, there was high fracture
incidence, and fatal hip and spine fracture than wrist are more
common than general people. The diagnosis and pharmaco-
logic treatment of osteoporosis were not done adequately, and
thus both medical staffs and patients should take this matter
into consideration.
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